阿里健康与广药集团签署全面战略合作协议

Core Insights - Alibaba Health and Guangzhou Pharmaceutical Group have signed a strategic cooperation agreement focusing on four key areas: deepening platform and supply chain collaboration, building a household expired medicine recycling system, exploring joint product development, and promoting compliant data sharing [1] Group 1: Strategic Cooperation - The partnership aims to enhance the efficiency and precision of Guangzhou Pharmaceutical's quality products reaching millions of families across the country through integrated online and offline services [1] - This collaboration marks a transition from sales synergy to a new phase of comprehensive digital operations and full-link service construction [1] Group 2: Company Profiles - Guangzhou Pharmaceutical Group is the world's first Fortune 500 company primarily focused on traditional Chinese medicine, with over 30 member enterprises and is a leading player in the biopharmaceutical industry in Guangdong Province and Guangzhou [2] - The company is accelerating its goal of becoming a world-class pharmaceutical health enterprise through modernization, technological advancement, digitalization, and internationalization [2] - Alibaba Health has positioned itself as a "new specialty drug launch platform," providing full-link support from drug launch to channel construction and patient services, and has become a partner to thousands of pharmaceutical companies globally [2]